Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ABBVIE-INC-12136589/news/AbbVie-Receives-CHMP-Positive-Opinion-for-Risankizumab-SKYRIZI-for-the-Treatment-of-Adults-with-36706984/?utm_source=whatsapp&utm_medium=social&utm_campaign=share